ALKS

Alkermes plc

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$46.98

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %29 / %30

Non-compliant assets / Total market cap %2.4 / %30

Non-compliant revenue / Total income %1.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders.

Website

Analysis (Turkish): ALKS Hissesi Caiz mi, Helal mi? Alkermes plc Katılım Analizi